18
Participants
Start Date
April 30, 2016
Primary Completion Date
December 31, 2018
Study Completion Date
April 30, 2019
ProxiScan
ProxiScan probe will be coupled with ProstaScint (a radioactive tracer) and used to perform imaging to detect small lesions in the pelvis that will otherwise be hard to detect with conventional imaging modalities.
Magnetic Resonance Imaging
Used as a comparative to ProxiScan.
SPECT-CT
Used as a comparative to ProxiScan.
Princess Margaret Cancer Centre, Toronto
Collaborators (1)
Hybridyne Imaging Technologies Inc
UNKNOWN
Aytu BioPharma, Inc.
INDUSTRY
University Health Network, Toronto
OTHER